The a2 Milk Co Ltd (ASX: A2M) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The a2 Milk Co Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.15 billion
P/E Ratio 29.61
Dividend Yield 0.00%
Shares Outstanding 721.98 million
Earnings per share 0.211
Dividend per share N/A
Year To Date Return 34.51%
Earnings Yield 3.38%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The a2 Milk Co Ltd (ASX: A2M)
    Latest News

    A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
    Earnings Results

    A2 Milk share price on watch amid stronger than expected FY23 results

    How did this infant formula company perform in FY 2023?

    Read more »

    Smiling man with phone in wheelchair watching stocks and trends on computer
    Share Market News

    5 things to watch on the ASX 200 on Monday

    Here's what to expect on the ASX 200 on Monday.

    Read more »

    two women looking intently at computer screen
    Consumer Staples & Discretionary Shares

    Own A2 Milk shares? Here's what to expect from its FY23 results

    Will this infant formula company deliver the goods in FY 2023?

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why A2 Milk, Azure Minerals, Beach, and Lake Resources shares are dropping

    These ASX shares are having a tough finish to the week.

    Read more »

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
    Consumer Staples & Discretionary Shares

    Here's what a top broker is saying about A2 Milk shares

    Is this infant formula a buy? Let's see what a top broker is saying.

    Read more »

    A man in a business suit holds a mobile phone to his ear while he drinks a large glass of milk.
    Consumer Staples & Discretionary Shares

    What's the forecast for the A2 Milk share price in August?

    Should investors stop being so sour on this infant formula giant?

    Read more »

    A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.
    Consumer Staples & Discretionary Shares

    The pros and cons of buying A2 Milk shares right now

    While there are reasons to hold off buying A2 Milk shares right now, some long-term investors might want to take…

    Read more »

    Young woman using computer laptop with hand on chin thinking about question, pensive expression.
    Consumer Staples & Discretionary Shares

    Can the A2 Milk share price regain its former highs in FY24?

    Where are A2 Milk shares heading in the new financial year?

    Read more »

    A man in a business suit holds a mobile phone to his ear while he drinks a large glass of milk.
    Consumer Staples & Discretionary Shares

    Are directors buying the dip on A2 Milk shares?

    Who has the conviction to keep buying A2 Milk shares after a steep sell-off?

    Read more »

    Consumer Staples & Discretionary Shares

    Does Bubs pose any real threat to the A2 Milk share price?

    A lot is going on behind the scenes at Bubs at the moment.

    Read more »

    A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.
    Consumer Staples & Discretionary Shares

    What might this week's Bubs US update mean for A2 Milk shares?

    Could the USA be what the doctor ordered to get A2 Milk shares heading higher again?

    Read more »

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    Here's why brokers believe that now could be the time to snap up these shares.

    Read more »

    Frequently Asked Questions

    The a2 Milk Company Ltd does not currently pay a dividend.

    The a2 Milk Company Ltd does not currently have a dividend reinvestment program.

    The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.

    A2M ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The a2 Milk Co Ltd

    A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.

    The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.

    After listing on the ASX in 2015, the A2M share price went from strength to strength, becoming one of Australia’s largest listed companies.

    However, the company has been under pressure since July 2020 amid a rapidly changing infant formula market and daigou channel in China. The A2M share price has plummeted from its then-high of around $20 to the current level today.

    A2M Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    16 Apr 2024 $5.59 $-0.14 -2.44% 3,214,522 $5.66 $5.66 $5.51
    15 Apr 2024 $5.73 $-0.09 -1.55% 949,031 $5.78 $5.80 $5.72
    12 Apr 2024 $5.82 $0.04 0.69% 1,123,374 $5.77 $5.84 $5.75
    11 Apr 2024 $5.78 $0.02 0.35% 2,003,635 $5.70 $5.82 $5.68
    10 Apr 2024 $5.76 $-0.06 -1.03% 1,355,370 $5.81 $5.82 $5.73
    09 Apr 2024 $5.82 $0.05 0.87% 1,880,426 $5.78 $5.84 $5.73
    08 Apr 2024 $5.77 $-0.03 -0.52% 1,326,438 $5.82 $5.84 $5.75
    05 Apr 2024 $5.80 $-0.11 -1.86% 2,824,860 $5.84 $5.90 $5.78
    04 Apr 2024 $5.91 $-0.11 -1.83% 4,836,524 $5.99 $6.00 $5.78
    03 Apr 2024 $6.02 $-0.08 -1.31% 1,697,395 $6.05 $6.09 $5.94
    02 Apr 2024 $6.10 $-0.15 -2.40% 2,745,915 $6.21 $6.22 $6.08
    28 Mar 2024 $6.25 $0.07 1.13% 3,517,109 $6.20 $6.25 $6.10
    27 Mar 2024 $6.18 $0.00 0.00% 2,065,558 $6.20 $6.20 $6.12
    26 Mar 2024 $6.18 $-0.05 -0.80% 1,652,046 $6.20 $6.21 $6.13
    25 Mar 2024 $6.23 $0.03 0.48% 1,430,906 $6.20 $6.26 $6.15
    22 Mar 2024 $6.20 $0.06 0.98% 2,465,897 $6.16 $6.24 $6.15
    21 Mar 2024 $6.14 $0.05 0.82% 5,607,403 $6.12 $6.22 $6.11
    20 Mar 2024 $6.09 $0.09 1.50% 2,428,248 $6.00 $6.10 $6.00
    19 Mar 2024 $6.00 $0.04 0.67% 1,483,437 $5.95 $6.02 $5.91

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Dec 2023 David Bortolussi Issued 690,066 $2,794,767
    Issue of securities. 1,682,152 performance rights
    30 Aug 2023 David Bortolussi Exercise 478,577 $2,249,311
    Conversion of securities. 992,086 performance rights
    30 Aug 2023 David Bortolussi Buy 478,577 $2,249,311
    Conversion of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Warwick Lynton Every-Burns Non-Executive Director Aug 2016
    Mr Every-Burns has been a career Consumer Packaged Goods (CPG) executive of global scale. His executive roles have included a successful career with The Clorox Company of the USA as Senior Vice President, International, based in the USA and prior to that as VP Asia Pacific. His earlier roles included Managing Director of NationalPak Limited (the Glad Products Company ultimately acquired by Clorox) and a career with Unilever PLC where he was based in Australia. He is a member of Risk Management Committee and chair of people committee.
    Mr David Landt Bortolussi Chief Executive OfficerManaging Director Feb 2021
    Mr Bortolussi spent five years at Foster's Group, where he held the role of Chief Strategy Officer responsible for corporate strategy, M&A, business development and performance improvement. Prior to Foster's Group, David held senior consulting roles at McKinsey & Company and PwC. David's career has largely been focused on the Consumer and Retail sector in Australia and New Zealand complemented by significant international experience in various markets and categories in China, SE Asia, EU and the USA.
    Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jul 2019
    Ms Greenwood is also a director on the boards of Westpac New Zealand, Spark New Zealand, Fisher & Paykel Healthcare and Vulcan Steel. She was previously a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's board including acting as the firm's board Chair and interim CEO. Pip brings extensive commercial and board experience to The a2 Milk Company board.
    Ms Kathryn(Kate) Mitchell Non-Executive Director Jun 2023
    Mr Mitchell has governance experience as a director of both private and public companies. She is currently Chair of The New Zealand Merino Company and Link Engine Management and a director of Heartland Group Holdings, FarmRight, and Christchurch International Airport, for which she also serves as Chair of the Risk, Audit & Finance Committee. Prior to moving to New Zealand in 2014, Kates executive career has 20 years in investment banking in London, which included senior leadership roles across several divisions within global investment banks including Deutsche Bank, Goldman Sachs and Merrill Lynch.
    Ms Sandra Yu Non-Executive Director Mar 2022
    Ms Yu is an experienced global executive in consumer goods industries, and in the infant milk formula (IMF) market in China, with a track record of driving business and brand transformation, leveraging opportunities for growth, and building organisational capabilities across China as well as the USA and other parts of Asia. As the former head of Mead Johnson Nutrition's Greater China business. Prior to that, Sandra held various other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally. Sandra was also appointed as the nonexecutive chairwoman to lead RB China's advisory board after the merger between Reckitt Benckiser and Mead Johnson Nutrition in 2017. Prior to joining Mead Johnson, Sandra held executive positions at Unilever, where she worked across Asia for thirteen years.
    Mr David Wang Non-Executive Director Sep 2022
    Mr Wang has over 30 years of experience across industrial and consumer goods businesses with expertise in manufacturing and supply chain including 15 years in senior executive leadership roles in China. He is currently the President of Asia Pacific for Buhler AG, a global leader in the provision of industrial solutions, which specialises in integrated plant equipment system and related services for food processing and advanced materials manufacturing. In this role, David has responsibility for nine manufacturing sites, eight research and development centres and overall supply chain operations across the Asia Pacific region including China, Indonesia, Japan, Korea, Malaysia, Philippines Thailand, Vietnam, Australia and New Zealand. Previously, David held various senior executive roles including at Blackstone AVINTIV Inc and Dover Corporation where his responsibilities covered manufacturing, research and development, technology and sales throughout Asia. Earlier in his career, David also worked with PepsiCo for almost 10 years in operations and supply chain.
    Mr Jaron McVicar Company SecretaryGeneral Counsel Nov 2016
    -
    Jaron McVicar Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 102,193,637 14.15%
    J P Morgan Nominees Australia Pty Limited 42,678,694 5.91%
    Citicorp Nominees Pty Limited 41,070,224 5.69%
    Bnp Paribas Nominees NZ Limited Bpss40 32,248,620 4.47%
    Tea Custodians Limited 25,502,735 3.53%
    HSBC Nominees (New Zealand) Limited 22,757,500 3.15%
    HSBC Nominees (New Zealand) Limited (iii) 22,307,717 3.09%
    Citibank Nominees (Nz) Ltd 20,759,419 2.88%
    Accident Compensation Corporation 19,790,745 2.74%
    JPMORGAN Chase Bank 19,756,171 2.74%
    New Zealand Superannuation Fund Nominees Limited 15,948,875 2.21%
    New Zealand Depository Nominee 15,850,202 2.20%
    National Nominees Limited 13,975,179 1.94%
    Bnp Paribas Noms Pty Ltd 10,635,729 1.47%
    Premier Nominees Limited 8,734,699 1.21%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 7,146,025 0.99%
    JBWERE (Nz) Nominees Limited 6,784,269 0.94%
    Public Trust 6,316,029 0.87%
    HSBC Custody Nominees (Australia) Limited (ii) 6,000,490 0.83%
    Custodial Services Limited 4,931,622 0.68%

    Profile

    since

    Note